Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rituximab for Pediatric Renal Transplant Rejection

This study has been completed.
Genentech and Biogen IDEC
Information provided by:
Stanford University Identifier:
First received: June 11, 2008
Last updated: December 19, 2008
Last verified: December 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2007
  Estimated Primary Completion Date: No date given